Literature DB >> 23581970

Effect of splenectomy on iron balance in patients with β-thalassemia major: a long-term follow-up.

Maddalena Casale1, Patrizia Cinque, Paolo Ricchi, Silvia Costantini, Anna Spasiano, Luciano Prossomariti, Salvatore Minelli, Valeria Frega, Aldo Filosa.   

Abstract

OBJECTIVE: A retrospective study was performed to explore the effect of splenectomy on iron balance in thalassemia major (TM).
METHODS: Twenty two TM patients treated with splenectomy were compared with a control group (non-splenectomized patients) matched for sex, age, pretransfusional Hb, chelation therapy, and duration of follow-up in a retrospective study to evaluate blood consumption, iron intake, and serum ferritin during an overall observation period of 6 yrs before and 10 yrs after splenectomy.
RESULTS: Splenectomy improved parameters of iron balance, determining a significant reduction in blood consumption (P < 0.01), iron intake (P < 0.01), and serum ferritin (P < 0.01). Comparing the two groups, blood consumption and iron intake were similar in presplenectomy period (P > 0.05), but serum ferritin was significantly higher in splenectomized patients (P < 0.01). After splenectomy, blood consumption and iron intake were significantly lower (P < 0.01) in splenectomized group while serum ferritin did not differ significantly (P > 0.05) between two groups, except for the first year (P < 0.05).
CONCLUSION: Splenectomy determines immediate drop in blood consumption and iron intake but slow downtrend of ferritin; direct measurements of iron overload, such as magnetic resonance studies, are needed to better understand the effect of splenectomy on iron balance parameters. Tailoring chelation therapy and eventually its intensification seem more efficient measures to manage iron accumulation in TM and to lower iron level to safety threshold.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23581970     DOI: 10.1111/ejh.12121

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  5 in total

1.  Therapeutic effects of induced pluripotent stem cells in chimeric mice with β-thalassemia.

Authors:  Guanheng Yang; Wansheng Shi; Xingyin Hu; Jingzhi Zhang; Zhijuan Gong; Xinbing Guo; Zhaorui Ren; Fanyi Zeng
Journal:  Haematologica       Date:  2014-05-09       Impact factor: 9.941

2.  Splenectomy for people with thalassaemia major or intermedia.

Authors:  Akshay Sharma; Manu Easow Mathew; Latika Puri
Journal:  Cochrane Database Syst Rev       Date:  2019-09-17

3.  Does Splenectomy Influence the Development of Hypothyroidism in Transfusion Dependent Thalassemia Patients? A Retrospective Study.

Authors:  Myrto Skafida; Christalena Sofocleous; Antonis Kattamis; Christos Kattamis
Journal:  Mediterr J Hematol Infect Dis       Date:  2019-11-01       Impact factor: 2.576

4.  The Link of Pancreatic Iron with Glucose Metabolism and Cardiac Iron in Thalassemia Intermedia: A Large, Multicenter Observational Study.

Authors:  Antonella Meloni; Laura Pistoia; Maria Rita Gamberini; Paolo Ricchi; Valerio Cecinati; Francesco Sorrentino; Liana Cuccia; Massimo Allò; Riccardo Righi; Priscilla Fina; Ada Riva; Stefania Renne; Giuseppe Peritore; Stefano Dalmiani; Vincenzo Positano; Emilio Quaia; Filippo Cademartiri; Alessia Pepe
Journal:  J Clin Med       Date:  2021-11-26       Impact factor: 4.241

5.  Successful Splenectomy for Hypersplenism in Wilson's Disease: A Single Center Experience from China.

Authors:  Liang-Yong Li; Wen-Ming Yang; Huai-Zhen Chen; Yun-Hu Wu; Xiang Fang; Jing Zhang; Zhen Wang; Yong-Sheng Han; Yu Wang
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.